FDA — authorised 9 September 1971
- Application: NDA016829
- Marketing authorisation holder: AAIPHARMA LLC
- Local brand name: DARVON-N W/ ASA
- Indication: CAPSULE — ORAL
- Status: approved
FDA authorised Aspirin loading dose on 9 September 1971
Yes. FDA authorised it on 9 September 1971.
AAIPHARMA LLC holds the US marketing authorisation.